Genetic Technologies
About:
Genetic Technologies is a molecular diagnostics company specializing in oncology.
Website: http://www.gtgcorporate.com
Top Investors: Kentgrove Capital
Description:
Genetic Technologies is a global molecular diagnostic business with an extensive range of international patents and a portfolio of tests and related services. Our aim is simple: to concentrate on markets where we can establish a long-term dominant position by providing tests that genuinely affect clinical outcomes. We are already the leading non-government genetic testing business in Australia, and through our wholly owned subsidiary Phenogen Sciences, we now have a solid and growing presence in the USA. We remain committed to the development of a global portfolio of cancer management tests. The first of which is the Breast Cancer Risk Assessment Test, BREVAGenTM.
$38.9M
$1M to $10M
Fitzroy, Victoria, Australia
1987-01-01
info(AT)gtglabs.com
101-250
2024-04-19
Public
© 2025 bioDAO.ai